WHO technical advisory group to take call on Covaxin EUL next week

Vaccine maker presented data before SAGE working group on Tuesday

The World Health Organization’s (WHO's) Technical Advisory Group (TAG) is expected to convene next week to carry out a risk-benefit assessment and come to a final decision on whether to grant emergency-use listing (EUL) to Bharat Biotech’s Covaxin.

A spokesperson for WHO told Business Standard that the EUL decision on Covaxin is still pending. “Bharat Biotech has been submitting the data to WHO on a rolling basis and submitted additional information at WHO’s request on September 27.”

WHO experts are currently reviewing this information. If it addresses all questions raised, WHO-TAG will carry out a risk-benefit assessment and come to